BOND Trial: Groundbreaking Support for Families with Congenital Heart Disease

Innovating Support for Families with Congenital Heart Disease

The recent launch of the BOND clinical trial marks a significant step toward better support for families of infants diagnosed with congenital heart disease (CHD). Conducted by Cincinnati Children's Hospital Medical Center in collaboration with the Pediatric Heart Network, this groundbreaking study seeks to provide essential emotional and practical assistance for parents during a critical time when their lives are turned upside down by the diagnosis of their newborn's heart condition.

Understanding the Challenge

Every year in the United States, approximately 40,000 infants are born with CHD, which can manifest in various forms, including holes in the heart, malformed valves, or more complex challenges like hypoplastic left heart syndrome. The struggle often begins during pregnancy or shortly after birth when families find themselves in the high-pressure environment of a cardiac intensive care unit. Instead of the joyful moments associated with welcoming a new baby, many parents face anxiety and uncertainty, worrying whether their child will survive the related medical interventions.

For these families, the emotional toll can be immense, leading to increased risks of anxiety and depression. Unfortunately, many parents lack the comprehensive support needed to navigate this challenging path, often feeling isolated and overwhelmed.

The BOND Clinical Trial: An Overview

The BOND trial, which stands for Building Optimal Strategies to Enhance Parent and Infant Wellbeing in Congenital Heart Disease, is set to run over the next three years involving 350 families across 12 core Pediatric Heart Network centers and five additional heart facilities. The research will focus on two innovative interventions designed to enhance both parental and infant well-being:

1. HeartGPS: A psychological support program tailored for expectant parents who learn that their baby has CHD. Spearheaded by Dr. Nadine Kasparian, this initiative will offer emotional guidance right from the point of diagnosis throughout the pregnancy and beyond.
2. Breastfeeding Support: A clinical practice guideline aimed at assisting mothers in successfully initiating and continuing breastfeeding, especially during intensive care stays. This effort will be directed by Dr. William Mahle from the Children's Hospital of Atlanta.

Changing the Narrative for Families

The primary goal of the BOND trial is to shift the experience of families from merely surviving the early challenges of CHD to thriving with the condition. Dr. Kasparian emphasizes the importance of building care models that empower parents, allowing them to feel connected and capable from the very beginning of their journey with CHD. The study seeks to explore how tailored emotional and practical support can lead to improved outcomes for both parents and infants.

With advancements in surgical and intensive care technologies, many newborns with CHD are now expected to survive, but the road ahead is often fraught with challenges related to development, feeding issues, and mental well-being. Through this trial, researchers aim to create a robust body of evidence to identify which interventions are most effective and when they should be introduced.